ALEXANDRIA, Va., June 25 -- United States Patent no. 12,337,030, issued on June 24, was assigned to Valo Therapeutics Oy (Helsinki).
"Viral vector" was invented by Vincenzo Cerullo (Helsinki), Cristian Capasso (Milan), Sara Feola (Helsinki) and Siri Tahtinen (Helsinki).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns a novel viral vector with modified viral capsid or viral envelope; a pharmaceutical composition or immunogenic agent or vaccine comprising same; a target cell transformed or transfected with same; a combination therapeutic comprising same; use of same in treatment of cancer, and a method of treating cancer using same."
The patent was filed on May 21, 2020, under Application ...